Pasithea Therapeutics Corp. (KTTA)
0.5731
-0.01
(-1.26%)
USD |
NASDAQ |
Sep 04, 12:26
Pasithea Therapeutics Total Assets (Quarterly) : 51.71M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 51.71M |
| March 31, 2026 | 56.35M |
| December 31, 2025 | 60.24M |
| September 30, 2025 | 13.63M |
| June 30, 2025 | 17.01M |
| March 31, 2025 | 14.66M |
| December 31, 2024 | 16.06M |
| September 30, 2024 | 18.64M |
| June 30, 2024 | 17.66M |
| March 31, 2024 | 22.41M |
| December 31, 2023 | 26.12M |
| Date | Value |
|---|---|
| September 30, 2023 | 30.66M |
| June 30, 2023 | 38.15M |
| March 31, 2023 | 42.04M |
| December 31, 2022 | 45.18M |
| September 30, 2022 | 49.61M |
| June 30, 2022 | 53.03M |
| March 31, 2022 | 51.08M |
| December 31, 2021 | 53.32M |
| September 30, 2021 | 21.04M |
| June 30, 2021 | 0.9248M |
| March 31, 2021 | 1.140M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
| Vericel Corp. | 502.87M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.870M |
| Shareholders Equity (Quarterly) | 49.84M |
| Current Ratio | 26.25 |
| Net Debt Paydown Yield | 0.31% |